<html>
<head>PUBMED IDs for SEC23A</head>
<body bgcolor='#C5F0F2'><h1>SEC23A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16980978/'>Secretory COPII coat component Sec23a is essential for craniofacial chondrocyte maturation.</a> September 19  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17981132/'>The genetic basis of a craniofacial disease provides insight into COPII coat assembly.</a> November 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19561605/'>Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.</a> September 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21593139/'>Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.</a> October 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23145914/'>ChIP-Chip Identifies SEC23A, CFDP1, and NSD1 as TFII-I Target Genes in Human Neural Crest Progenitor Cells.</a> April 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23453696/'>Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II.</a> January 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23935019/'>Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis.</a> July 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25683121/'>Mutations in SEC24D, encoding a component of the COPII machinery, cause a syndromic form of osteogenesis imperfecta.</a> May 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27036030/'>MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib.</a> April 2  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27148587/'>Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A.</a> May 6  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27297878/'>Pancreatic SEC23B deficiency is sufficient to explain the perinatal lethality of germline SEC23B deficiency in mice.</a> June 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27297871/'>Recurrent mutations in genes involved in nuclear factor-ÎºB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.</a> June 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27832783/'>miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.</a> June 16  2016<br></body></html>
